Category: Zimmer Holdings
Orthopedics giant Zimmer announces the U.S. launch of its next-generation Optio-C stand-alone cervical implant.
Zimmer (NYSE:ZMH) announced U.S. commercialization for its next-generation Optio-C cervical implant, calling the device a vital milestone future development.
Here's a look at some of the top funding stories for medical device companies this week.
, Altitude Technologies
, Bi02 Medical
, Draeger Medical
, Google Inc.
, OnTarget Laboratories
, Targeted Technology Fund
, Texas Emerging Technology Fund
, U.S. Defense Dept.
Medical device makers Zimmer, Draeger Medical and Altitude Technologies collect Dept. of Defense contracts worth a collective $234.3 million.
A trio of medical device makers collected Pentagon supply deals worth a collective $234.3 million, according to recent Defense Dept. reports.
RTI Surgical subsidiary Pioneer Surgical Technology renews a supply deal with Zimmer's trauma division.
Zimmer Holdings accuses Stryker Corp. and a former Zimmer sales rep of scheming to create a 'Trojan Horse' plan designed to lure Zimmer reps to work for Stryker.
4th-quarter profits surge more than 50% for Zimmer Holdings, sending share prices up.
Zimmer (NYSE:ZMH) beat expectations for its 4th-quarter sales and earnings, sending share prices up today as the medical device company's 2014 forecast falls in line with Wall Street's outlook.
Orthopedics giant Zimmer embarks on a $1 billion share repurchase program with the board of directors' approval.
Orthopedic devices titan Zimmer (NYSE:ZMH) launched a new open-ended buyback program under which the board approved the repurchase of up to $1 billion in shares.